JPY 4209.0
(-1.91%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 31.22 Billion JPY | 15.74% |
2022 | 25.79 Billion JPY | 8.22% |
2021 | 24.05 Billion JPY | 16.01% |
2020 | 19.43 Billion JPY | -15.13% |
2019 | 24.51 Billion JPY | 1.85% |
2018 | 24.13 Billion JPY | -10.73% |
2017 | 26.95 Billion JPY | 23.74% |
2016 | 21.79 Billion JPY | 4.22% |
2015 | 20.24 Billion JPY | 28.61% |
2014 | 15.74 Billion JPY | 12.4% |
2013 | 14.66 Billion JPY | 4.06% |
2012 | 13.83 Billion JPY | -11.67% |
2011 | 12.95 Billion JPY | 21.69% |
2010 | 10.41 Billion JPY | 20.88% |
2009 | 8.56 Billion JPY | 16.74% |
2008 | 9.46 Billion JPY | 14.83% |
2007 | 8.24 Billion JPY | 33.64% |
2006 | 6.16 Billion JPY | 6.23% |
2005 | 5.8 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 5.45 Billion JPY | -12.11% |
2023 Q2 | 5.46 Billion JPY | 40.52% |
2023 Q3 | 8.33 Billion JPY | 52.44% |
2023 Q1 | 3.88 Billion JPY | -17.73% |
2023 Q4 | 11.68 Billion JPY | 40.31% |
2023 FY | - JPY | 15.74% |
2022 Q4 | 4.72 Billion JPY | -7.26% |
2022 Q2 | 4.21 Billion JPY | 35.79% |
2022 Q1 | 3.1 Billion JPY | -39.98% |
2022 FY | - JPY | 8.22% |
2022 Q3 | 5.09 Billion JPY | 21.04% |
2021 Q2 | 3.27 Billion JPY | 13.95% |
2021 Q4 | 5.16 Billion JPY | 10.26% |
2021 Q1 | 2.87 Billion JPY | -41.66% |
2021 Q3 | 4.68 Billion JPY | 43.08% |
2021 FY | - JPY | 16.01% |
2020 Q3 | 3.34 Billion JPY | 10.78% |
2020 FY | - JPY | -15.13% |
2020 Q2 | 3.01 Billion JPY | 97.45% |
2020 Q4 | 4.92 Billion JPY | 47.49% |
2020 Q1 | 1.52 Billion JPY | -59.95% |
2019 Q1 | 4.23 Billion JPY | -0.09% |
2019 Q2 | 4.56 Billion JPY | 7.92% |
2019 Q3 | 4.26 Billion JPY | -6.68% |
2019 FY | - JPY | 1.85% |
2019 Q4 | 3.81 Billion JPY | -10.53% |
2018 Q3 | 5.43 Billion JPY | 56.81% |
2018 Q2 | 3.46 Billion JPY | -4.65% |
2018 FY | - JPY | -10.73% |
2018 Q4 | 4.23 Billion JPY | -22.06% |
2018 Q1 | 3.63 Billion JPY | -33.42% |
2017 FY | - JPY | 23.74% |
2017 Q3 | 6.12 Billion JPY | 34.2% |
2017 Q1 | 4.16 Billion JPY | -16.96% |
2017 Q2 | 4.56 Billion JPY | 9.39% |
2017 Q4 | 5.45 Billion JPY | -10.81% |
2016 Q1 | 2.4 Billion JPY | -49.0% |
2016 FY | - JPY | 4.22% |
2016 Q3 | 4.72 Billion JPY | 57.58% |
2016 Q4 | 5.02 Billion JPY | 6.16% |
2016 Q2 | 3 Billion JPY | 24.58% |
2015 FY | - JPY | 28.61% |
2015 Q4 | 4.72 Billion JPY | 10.83% |
2015 Q3 | 4.26 Billion JPY | 21.71% |
2015 Q2 | 3.5 Billion JPY | 20.48% |
2015 Q1 | 2.9 Billion JPY | -28.56% |
2014 Q2 | 2.64 Billion JPY | 43.4% |
2014 FY | - JPY | 12.4% |
2014 Q3 | 3.39 Billion JPY | 28.23% |
2014 Q1 | 1.84 Billion JPY | -33.13% |
2014 Q4 | 4.06 Billion JPY | 19.86% |
2013 Q2 | 2.71 Billion JPY | 8.12% |
2013 Q3 | 2.65 Billion JPY | -2.35% |
2013 Q4 | 2.76 Billion JPY | 4.04% |
2013 Q1 | 2.51 Billion JPY | -15.81% |
2013 FY | - JPY | 4.06% |
2012 Q1 | 2.36 Billion JPY | -57.15% |
2012 Q2 | 2.16 Billion JPY | -8.53% |
2012 Q3 | 2.84 Billion JPY | 31.62% |
2012 Q4 | 2.98 Billion JPY | 4.9% |
2012 FY | - JPY | -11.67% |
2011 FY | - JPY | 21.69% |
2011 Q4 | 5.51 Billion JPY | 100.06% |
2011 Q3 | 2.75 Billion JPY | 4.34% |
2011 Q2 | 2.64 Billion JPY | 13.81% |
2011 Q1 | 2.32 Billion JPY | -58.97% |
2010 Q2 | 2.51 Billion JPY | 14.9% |
2010 Q4 | 5.65 Billion JPY | 89.51% |
2010 Q1 | 2.19 Billion JPY | -54.84% |
2010 FY | - JPY | 20.88% |
2010 Q3 | 2.98 Billion JPY | 18.62% |
2009 Q1 | 1.94 Billion JPY | -55.44% |
2009 Q4 | 4.85 Billion JPY | 112.55% |
2009 Q3 | 2.28 Billion JPY | 15.98% |
2009 FY | - JPY | 16.74% |
2009 Q2 | 1.96 Billion JPY | 1.28% |
2008 Q3 | 1.92 Billion JPY | 57.69% |
2008 FY | - JPY | 14.83% |
2008 Q4 | 4.36 Billion JPY | 126.87% |
2008 Q2 | 1.21 Billion JPY | 0.0% |
2007 FY | - JPY | 33.64% |
2006 FY | - JPY | 6.23% |
2005 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
HEARTSEED INC | -1.44 Billion JPY | 2255.819% |
Cawachi Limited | 11.85 Billion JPY | -163.432% |
Pharmarise Holdings Corporation | 2.08 Billion JPY | -1396.74% |
Qol Holdings Co., Ltd. | 14.21 Billion JPY | -119.703% |
MatsukiyoCocokara & Co. | 98.01 Billion JPY | 68.147% |
Welcia Holdings Co., Ltd. | 67.62 Billion JPY | 53.831% |
Create SD Holdings Co., Ltd. | 24.34 Billion JPY | -28.232% |
NIHON CHOUZAI Co.,Ltd. | 14.65 Billion JPY | -113.047% |
COSMOS Pharmaceutical Corporation | 51.42 Billion JPY | 39.288% |
Tsuruha Holdings Inc. | 67.2 Billion JPY | 53.543% |
Ohki Healthcare Holdings Co.,Ltd. | 3.81 Billion JPY | -718.187% |
Satudora Holdings Co.,Ltd. | 2.71 Billion JPY | -1051.254% |
Kusuri No Aoki Holdings Co., Ltd. | 30.64 Billion JPY | -1.896% |
Medical System Network Co., Ltd. | 6.99 Billion JPY | -346.284% |
Shinnihonseiyaku Co., Ltd. | 4.18 Billion JPY | -645.511% |
Sugi Holdings Co.,Ltd. | 50.74 Billion JPY | 38.472% |
YAKUODO HOLDINGS Co., Ltd. | 8.16 Billion JPY | -282.482% |
Astena Holdings Co., Ltd. | 4.17 Billion JPY | -648.33% |
Genky DrugStores Co., Ltd. | 14.47 Billion JPY | -115.711% |
Sundrug Co.,Ltd. | 56.23 Billion JPY | 44.483% |